Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Associate Professor Katherine Samaras

 

Research Fellow; Head, Diabetes and Obesity Clinical Studies, Diabetes and Obesity Research Program, Garvan Institute of Medical Research; Senior Staff Specialist Department of Endocrinology, St Vincent's Hospital; Consultant endocrinologist, St Vincent's Clinic

Email: k.samaras 'at' garvan.org.au
Research Group: Samaras

 
 

Education
2001 PhD, University of NSW
1996 Fellowship, Royal Australasian College of Physicians
1988 MBBS (Hons) , University of NSW

Awards and honours
2007  Senior Scientist group, Garvan Institute
2005  NHMRC-Diabetes Australia RD Wright Fellowship /Career Development Award
2004  Garvan Publication Prize for Lancet paper
2004 Garvan Publication Prize for Circulation paper
2001 Diabetes Australia Fellowship, Royal Australasian College of Physicians
2001 St Vincent's Clinic Foundation Research Grant
2000 Best Thesis Prize for 2000, Garvan Institute of Medical Research
2000 HRT Paper selected as "Hot Paper", Yearbook of Endocrinology
2000 Twin Paper selected as "Hot Paper", Yearbook of Endocrinology Endocrine Society of America
2000 Co-chair, Diabetes Research Roundtable Meeting, Parliament House, Canberra
1999 Garvan Publication Prize for Lancet paper
1999 Garvan Publication Prize for Annals of Internal Medicine paper
1999 American Diabetes Society: Commendation: outstanding reviewer
1996-8 National Health and Medical Research Council Postgraduate Medical Scholarship
1996 Young Investigator Award, Australasian Society for the Study of Obesity

Publications

Samaras K, Wand H, Law M, Emery S, Cooper DA, Carr A. Metabolic Syndrome in HIV-infected patients using IDF and ATPIII criteria: prevalence, discordance and clinical utility. Diabetes Care 2007, 30: 113-9.

Samaras K. Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 (HIV) infection. (Invited review). J Antimicrobial Chemotherapy (in press).

Samaras K, Chisholm DJ. Diabetes, insulin resistance and glucose metabolism in HIV infection and its treatment. In: The Epidemiology of Diabetes Mellitus: An International Perspective. Eds: Ekoe J-M, Zimmet P, Williams R, Rewers M. John Wiley and Sons (in press).

Bradbury R, Samaras K. Anti-retroviral therapy and the human immunodeficiency virus- improved survival but at what cost? Diabetes Obesity and Metabolism (in press), accepted 15/6/07.

Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG, Cooper DA, Emery S. Metabolic Syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infection. AIDS 2007 (in press).

Samaras K. Insulin resistance in treated HIV-infection. (Invited review). Diabetes Management Journal 2007 (in press).

Samaras K, McElduff A, Twigg S, Proietto J, Prins JB, Welborn TA, P Zimmet, Chisholm DJ, Campbell LV. Insulin resistance: Phantom of the Metabolic Opera. Med J Aust 2006; 185; 159-61.

Greenfield JR, Samaras K. Evaluation of pituitary function in the fatigued patient: a review of 59 cases. European J Endocrinol 2006; 154: 147-157.

Greenfield JR, Samaras K. Suppression of HPA axis in adults taking inhaled corticosteroids. Thorax 2006; 61: 271-2.2.

Greenfield JR, Samaras K, Chisholm DJ, Campbell LV. "Effect of postprandial insulinaemia and insulin resistance on measurement of arterial stiffness (augmentation index). International J Cardiol 2007; 114: 50-6.

Mallon PWG, Miller J, Kovacic J, Kent-Hughes J, Norris R, Samaras K, Feneley M, Cooper DA, Carr A. Changes in body composition and surrogate markers of cardiovascular disease in hypercholesterolaemic HIV-infected men treated with pravastatin - a randomised, placebo-controlled study. AIDS 2006; 20: 1003-1010.

Samaras K, Campbell LV. Insulin resistance: more important to identify than quantitate. Nephrology 2005 10; 597-8.

Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA. Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in HIV-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases. J Clin Endocrinol Metab 2005; 90: 9394-8.

Greenfield J, Samaras K, Chisholm DJ, Campbell LV. Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance. J Clin Endocrinol Metab 2005; 90: 661-72.

Mallon PWG, Unemori P, Sedwell R, Morey A, Rafferty M, Williams K, Chisholm D, Samaras K, Emery S, Kelleher A, Cooper DA, Carr A.  In vivo, nucleoside reverse transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of mitochondrial DNA depletion. J Infectious Diseases; 2005;191: 1686-96.

 

Search for all publications by K Samaras

 
 
 

Areas of Interest

diabetes, diabetes risk, insulin resistance, insulin secretion, obesity, metabolic syndrome, endocrine compliocations of HIV-infection and its treatment
 

News

 

Fighting illnesses that accompany the latest anti-psychotic drugs

MEDIA RELEASE: 11 Jan 2012
Anti-psychotic drugs for treating serious mental illnesses, such as bipolar disorder or schizophrenia, are effective and often life-saving but come with unwelcome side effects. They dramatically increase weight as well as the incidence of metabolic disorders such as raised blood fats and Type 2 diabetes, say Sydney-based specialists. The rapid decline in physical health is so clinically significant, and of such concern, that the specialists put together a physical health protection algorithm last year.
 
 

Why a common HIV drug increases risk of heart attack

MEDIA RELEASE: 28 Jul 2010
Clinical researchers at Garvan and St. Vincent's Hospital have for the first time shown why a commonly used type of HIV drug is associated with a higher risk of heart attack.
 
 

The remarkable effects of fat loss on the immune system

MEDIA RELEASE: 20 Apr 2010
Garvan scientists have shown for the first time that even modest weight loss reverses many of the damaging changes often seen in the immune cells of obese people, particularly those with Type 2 diabetes.
 
 

Personal tools